Articles From: Arrowhead Closes $36 Million Private Offering to Artesian Resources Corporation Announces a 1.5% Increase in Common Stock Dividend


2013/5/6
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that on May 3, 2013 it closed a previously announced private offering of common and convertible preferred stock with gross proceeds of $36 million.
Sign-up for Arrowhead Closes $36 Million Private Offering investment picks
2013/2/26
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced the publication of data demonstrating multi-log reductions in hepatitis B viral DNA and proteins lasting over 30 days after a single injection in animal models.
Sign-up for Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus investment picks
2013/3/25
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, will host an analyst event today in New York City to discuss ARC-520, its RNAi-based candidate designed to treat chronic hepatitis B virus infection.
Sign-up for Arrowhead Induces 90% Reduction in Hepatitis B Antigens in Chimpanzee with Chronic Infection: Data Follow Previous Report of Reduction in Viral DNA investment picks
2013/4/29
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it has priced a private offering with gross proceeds expected to be $36 million.
Sign-up for Arrowhead Prices $36 Million Private Offering investment picks
2013/2/28
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Number 13/336,028 entitled, “In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages.” This new IP expands the Dynamic Polyconjugate (DPC) platform, broadly protecting Arrowhead's next generation DPC polymer masking technology.
Sign-up for Arrowhead Receives Notice of Patent Allowance for New Protease Sensitive Masking Chemistry for DPC siRNA Delivery System investment picks
2013/5/7
Arrowhead Research Corporation (NASDAQ:ARWR) , a targeted therapeutics company, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Number 13/326,433 entitled, “Peptide-Based In Vivo siRNA Delivery System.” The allowed claims specifically protect the use of targeted melittin or melittin-like peptides to facilitate delivery of siRNA conjugates to hepatocytes.
Sign-up for Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone investment picks
2013/2/13
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced financial results for its fiscal 2013 first quarter ended December 31, 2012.
Sign-up for Arrowhead Reports Fiscal 2013 First Quarter Financial Results investment picks
2013/5/9
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced financial results for its fiscal 2013 second quarter ended March 31, 2013.
Sign-up for Arrowhead Reports Fiscal 2013 Second Quarter Financial Results investment picks
2013/3/14
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that a study of its RNAi-based candidate ARC-520 in a chimpanzee chronically infected with the human hepatitis B virus (HBV) supports findings from rodent models indicating that it can knock down HBV DNA and key viral antigens.
Sign-up for Arrowhead RNAi Candidate ARC-520 Induces Greater than 90% Reduction in Circulating HBV DNA in Chimpanzee with Chronic Hepatitis B investment picks
2013/3/7
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it will host an analyst and investor event on Monday, March 25, from 12:30 to 2:00 p.m. EST in New York City.
Sign-up for Arrowhead to Host Analyst Event in New York to Discuss RNAi-based Hepatitis B Candidate ARC-520 investment picks
2013/4/24
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that its President and CEO, Dr.
Sign-up for Arrowhead to Present at Master Investor 2013 investment picks
2013/4/24
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that its COO and Head of R&D, Dr.
Sign-up for Arrowhead to Present at Needham Healthcare Conference investment picks
2013/2/1
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that academic collaborators and scientists from the company will present data on the Dynamic PolyConjugate™ (DPC) siRNA delivery system, the ARC-520 hepatitis B drug candidate, and the Homing Peptide™ platform at upcoming scientific conferences.
Sign-up for Arrowhead to Present at Upcoming Scientific Conferences investment picks
2013/5/13
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that the company will present data on the Dynamic PolyConjugate™ (DPC) siRNA delivery system and the ARC-520 hepatitis B drug candidate at upcoming scientific conferences.
Sign-up for Arrowhead to Present at Upcoming Scientific Conferences investment picks
2013/2/6
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it will report its financial results for the fiscal 2013 first quarter ended December 31, 2012, on Wednesday, February 13, 2013 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 877-317-6789 (toll free from the US), 866-605-3852 (toll free from Canada), or 412-317-6789 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at www.arrowheadresearch.com .
Sign-up for Arrowhead to Report Fiscal 2013 First Quarter Financial Results investment picks
2013/5/2
Arrowhead Research Corporation (NASDAQ:ARWR) , a targeted therapeutics company, today announced that it will report its financial results for the fiscal 2013 second quarter ended March 31, 2013, on Thursday, May 9, 2013, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 877-317-6789 (toll free from the US), 866-605-3852 (toll free from Canada), or 412-317-6789 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at www.arrowheadresearch.com .
Sign-up for Arrowhead to Report Fiscal 2013 Second Quarter Financial Results investment picks
2013/3/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0861065001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Energy Inc. Announces 2012 Fourth Quarter and Year End Results investment picks
2013/5/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0871729001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Energy Releases Q1 Results and Announces Dividend Plans investment picks
2013/2/28
Advanced Refining Technologies LLC (ART) announced that it has signed an agreement with Chevron Lummus Global (CLG) regarding hydrocracking and lubes hydroprocessing catalysts.
Sign-up for ART Announces CLG Hydrocracking Catalysts Sales Agreement investment picks
2013/3/25
Two of the Biggest Names in Home Decor and Design Trends Unite as Art Van Furniture Becomes the Exclusive Michigan Retailer for HGTV HOME™ Furniture Collection WARREN, Mich.
Sign-up for Art Van Furniture Brings It Home With HGTV HOME™ Furniture Collection investment picks
2013/4/15
Conference Call Scheduled For Monday, April 15, 2013 at 10:00 AM CT ARMSTRONG, Iowa , April 15, 2013 /PRNewswire/ -- Art's Way Manufacturing Co., Inc. (NASDAQ: ARTW) , a leading manufacturer and distributor of agricultural machinery, equipment and services is pleased to announce its financial results for the three months ended February 28, 2013 .
Sign-up for Art's Way Manufacturing Announces 33.3% Increase In Year Over Year First Quarter Net Sales investment picks
2013/2/25
Net Income For Fiscal Year 2012 Increases 113.4% To $2.7 Million Net Sales Increases 31.9% To $36.5 Million Earnings Per Share Increases 112.9% to $0.66 Conference Call Scheduled For Tuesday, February 26, 2013 at 10:00 a.m. Central Time ARMSTRONG, Iowa , Feb.
Sign-up for Art's Way Manufacturing Announces Financial Results For The Fiscal Year 2012 investment picks
2013/4/11
ARMSTRONG, Iowa , April 11, 2013 /PRNewswire/ -- Art's Way Manufacturing Co., Inc. (NASDAQ: ARTW) , a leading manufacturer and distributor of agricultural machinery, equipment and services, announces it will report financial results for its first quarter on Monday, April 15, 2013 .
Sign-up for Art's Way Manufacturing Co., Inc. First Quarter Earnings Call Scheduled For April 15, 2013 investment picks
2013/2/21
ARMSTRONG, Iowa , Feb.
Sign-up for Art's Way Manufacturing Co., Inc. Fourth Quarter and Year-End Earnings Call Scheduled for February 26, 2013 investment picks
2013/4/24
ARMSTRONG, Iowa , April 24, 2013 /PRNewswire/ -- Art's Way Manufacturing Co., Inc. (NASDAQ: ARTW) , a leading manufacturer and distributor of agricultural machinery, equipment and services, and Rojac Industries, Inc. announce they have signed a letter of intent.
Sign-up for Art's Way Manufacturing Signs Letter Of Intent To Purchase Assets Of Agro Trend Manufacturing investment picks
2013/3/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0861732001&sourceType=1 http://media3.marketwire.com/docs/arteklogoLG.png CALGARY, ALBERTA --
Sign-up for Artek Announces Record Year End 2012 Financial and Operating Results investment picks
2013/5/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0873925001&sourceType=1 http://media3.marketwire.com/docs/arteklogoLG.png CALGARY, ALBERTA --
Sign-up for Artek Exploration Ltd. Announces First Quarter 2013 Financial Results and Updates Operations investment picks
2013/3/19
Artesian Water Company, Inc., a subsidiary of Artesian Resources Corporation (NASDAQ: ARTNA) , and the Town of Chesapeake City are pleased to announce the successful completion of an interconnection that will provide a new source of high quality water service to the Chesapeake City community.
Sign-up for Artesian and the Town of Chesapeake City, Maryland Complete Connection to Supply Water to the Town investment picks
2013/2/25
Artesian Wastewater Management, Inc. (AWMI), a wholly owned subsidiary of Artesian Resources Corporation (NASDAQ: ARTNA) , has filed an application with the Delaware Public Service Commission requesting a general rate increase for the provision of wastewater services.
Sign-up for Artesian Files Rate Case Request for Wastewater System Improvements investment picks
2013/4/26
Artesian Resources Corporation (NASDAQ: ARTNA) announced today that its Board of Directors has approved a 1.5% increase in the company’s Class A and Class B Common Stock dividend, raising the annual dividend to $0.8228 per share.
Sign-up for Artesian Resources Corporation Announces a 1.5% Increase in Common Stock Dividend investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Arrowhead Closes $36 Million Private Offering to Artesian Resources Corporation Announces a 1.5% Increase in Common Stock Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity